Eculizumab: A Review of Its Use in Atypical Haemolytic Uraemic Syndrome

Overview of attention for article published in Drugs, November 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

policy: 1 policy source
twitter: 1 X user

patent: 5 patents
wikipedia: 10 Wikipedia pages

Readers on

mendeley: 107 Mendeley

Summary Policy documents X Patents Wikipedia

So far, Altmetric has seen 1 policy document that references this research output.

Management of Atypical Hemolytic Uremic Syndrome: Clinical Effectiveness and Guidelines

Cited by Canadian Agency for Drugs and Technologies in Health on 30 May 2018

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.